Article
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
The Lancet. Oncology - 1 Nov 2010
de Sanjose Silvia, Quint Wim Gv, Alemany Laia, Geraets Daan T, Klaustermeier Jo Ellen, Lloveras Belen, Tous Sara, Felix Ana, Bravo Luis Eduardo, Shin Hai-Rim, Vallejos Carlos S, de Ruiz Patricia Alonso, Lima Marcus Aurelho, Guimera Nuria, Clavero Omar, Alejo Maria, Llombart-Bosch Antonio, Cheng-Yang Chou, Tatti Silvio Alejandro, Kasamatsu Elena, Iljazovic Ermina, Odida Michael, Prado Rodrigo, Seoud Muhieddine, Grce Magdalena, Usubutun Alp, Jain Asha, Suarez Gustavo Adolfo Hernandez, Lombardi Luis Estuardo, Banjo Aekunbiola, Menéndez Clara, Domingo Efrén Javier, Velasco Julio, Nessa Ashrafun, Chichareon Saibua C Bunnag, Qiao You Lin, Lerma Enrique, Garland Suzanne M, Sasagawa Toshiyuki, Ferrera Annabelle, Hammouda Doudja, Mariani Luciano, Pelayo Adela, Steiner Ivo, Oliva Esther, Meijer Chris Jlm, Al-Jassar Waleed Fahad, Cruz Eugenia, Wright Thomas C, Puras Ana, Llave Cecilia Ladines, Tzardi Maria, Agorastos Theodoros, Garcia-Barriola Victoria, Clavel Christine, Ordi Jaume, Andújar Miguel, Castellsagué Xavier, Sánchez Gloria I, Nowakowski Andrzej Marcin, Bornstein Jacob, Muñoz Nubia, Bosch F Xavier
Abstract excerpt
BACKGROUND: Knowledge about the distribution of human papillomavirus (HPV) genotypes in invasive cervical cancer is crucial to guide the introduction of prophylactic vaccines. We aimed to provide novel and comprehensive data about the worldwide genotype distribution in patients with invasive cervical cancer. METHODS: Paraffin-embedded samples of histologically confirmed cases of invasive cervical cancer were...
Topics
- Adenocarcinoma
- Adolescent
- Adult